$OKLO

Narayanadas Vivek sold $9K of OKLO

Narayanadas Vivek (General Counsel & Secretary) sold 223 shares of Oklo Inc. (OKLO) at $40.80 on 2026-08-25 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Narayanadas Vivek
Published Aug 27, 2026, 8:34 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 27, 2026, 8:37 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$OKLO
Neutral
high confidence
Mentioned
$OKLO
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OKLONeutralLow
01

Why it matters

The disclosed sale is routine and unlikely to affect market perception or price.

02

Market read

Minor insider transaction with negligible trading relevance.

03

What to watch

Potential future insider transactions if the 10b5‑1 plan is part of a larger sell‑down schedule.

Relevance 2/10Novelty 4/10Timing: post‑filing today

Background

Oklo Inc. is a U.S. listed nuclear‑fuel company. Form 4 filings disclose insider trades and are required by the SEC.

Company-level read

Ticker impact

$OKLONeutralHigh confidence
Context

General Counsel sold 223 shares for $9,098 via a 10b5‑1 plan, reducing his holding to 7,599 shares.

Expected impact

No significant price impact expected.

Evidence & confidence

The transaction size is small relative to market cap and disclosed via a Form 4, which is a routine filing.

Market effects

None; the sale does not affect the nuclear energy sector broadly.

None; limited to Oklo shareholders.

None

Counterpoint

The sale could signal insider concern, but the amount is too small to warrant a contrarian trade.

Key entities

  • Narayanadas Vivek

    General Counsel & Secretary of Oklo, reporting a 10b5‑1 sale of 223 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HNUCMed

A New Nuclear Rival Recently Filed to Go Public. Should Oklo Investors Be Worried?

Holtec Nuclear Corporation filed for an IPO on Nasdaq (ticker HNUC), generating $165M revenue and $17.8M net income in Q1 2024. Unlike Oklo (OKLO), Holtec has existing revenue and earnings, focusing on nuclear equipment, waste management, and SMR development. Holtec plans to use IPO proceeds for SMR programs and expansion. Oklo, a pre-commercial nuclear startup, has minimal revenue and significant losses, raising concerns for investors.

$CCJMedAI 8/10

AI Energy Demands Surge, Nuclear Power Seeks to Break the Deadlock

Nuclear energy sector is poised for long-term growth due to rising AI data center demand and government policies. Cameco (CCJ) benefits from uranium mining and reactor manufacturing. GE Vernova (GEV) is developing small modular reactors with a project scheduled for 2029. High-risk startups Oklo (OKLO) and NuScale Power (SMR) are seeking commercial agreements for future deployment.

MedAI 8/10

Oklo aims to turn nuclear waste into clean energy

Oklo Inc. plans to invest $1.68B to build a nuclear fuel recycling facility in Oak Ridge, converting used nuclear fuel into reusable materials. The company aims to address rising electricity demand and domestic HALEU supply shortages. Christina Leggett, director of fuel cycle technology, leads the project, leveraging pyroprocessing technology.

$OKLOMed

Oklo Climbs 12% As Supply Concerns Spark Rally In Advanced Nuclear Stocks

Oklo (OKLO) stock rose 12% to $44 on supply concerns amid U.S.-Canada trade tensions, adding $850M to its market cap. The company's Aurora reactors rely on advanced fuels, and recent political developments highlight risks tied to material access. Oklo has strong cash reserves ($3.01B) and operational milestones, like its Groves reactor reaching criticality. Analysts' price targets range from $14 to $130, with an average of $80.